Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS??? EQUITY (Details Narrative)

v3.24.1.1.u2
STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Accumulated Other Comprehensive Income (Loss) [Line Items]    
Unrecognized stock-based compensation expense $ 3,228,000  
Weighted average remaining vesting period 1 year 3 months 18 days  
Share-based compensation arrangement by share-based payment award, number of shares available for grant 141,275  
Grant date fair value $ 467  
At The Market Offering [Member]    
Accumulated Other Comprehensive Income (Loss) [Line Items]    
Gross proceeds 25,651,000  
Issuance costs 581,000  
Net proceeds $ 25,070,000  
Common Stock [Member]    
Accumulated Other Comprehensive Income (Loss) [Line Items]    
shares of common stock 8,177,472  
Gross proceeds $ 25,651,000  
Issuance costs $ 581,000  
Common Stock [Member] | Employee of The Company and Consultants 2 [Member]    
Accumulated Other Comprehensive Income (Loss) [Line Items]    
Stock Issued During Period, Shares, Issued for Services   837
Number of common shares issued, value   $ 2,000
Common Stock [Member] | At The Market Offering [Member]    
Accumulated Other Comprehensive Income (Loss) [Line Items]    
shares of common stock 8,177,472  
Stock Options and Warrants [Member]    
Accumulated Other Comprehensive Income (Loss) [Line Items]    
Sharebased compensation expense $ 917,000 $ 7,775,000